I dont get it. Avagadro is only stating what's been obvious to anyone over the last 12 months. The market wants clinical trial results, not preclinical. There won't be a rerate until we see significant positive results. Until then the price will tread water.
- Forums
- ASX - By Stock
- Ann: MD Anderson Preclinical AML Study on Zantrene Published
I dont get it. Avagadro is only stating what's been obvious to...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.79 |
Change
-0.025(1.38%) |
Mkt cap ! $305.0M |
Open | High | Low | Value | Volume |
$1.81 | $1.82 | $1.79 | $45.89K | 25.50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3341 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 2456 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 486 | 1.790 |
1 | 6531 | 1.775 |
1 | 8500 | 1.770 |
1 | 4835 | 1.760 |
1 | 1000 | 1.755 |
Price($) | Vol. | No. |
---|---|---|
1.795 | 500 | 1 |
1.800 | 2456 | 2 |
1.810 | 253 | 1 |
1.815 | 398 | 1 |
1.820 | 2315 | 1 |
Last trade - 10.53am 27/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |